Form EFFECT Adverum Biotechnologies,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312795 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SBA Reforms 8(a) Business Development Program to End Racial Discrimination in Federal Contracting
- Blast Media Print Earns a GUINNESS WORLD RECORDS® Title for the Largest Flag Unfurled on a Mountain
- Reese Apartments Grand Opening Marks 48 New Affordable Housing Units, Fully Leased in Six Weeks
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
